View Financial HealthDanaher 배당 및 자사주 매입배당 기준 점검 3/6Danaher 수익으로 충분히 충당되는 현재 수익률 0.93% 보유한 배당금 지급 회사입니다.핵심 정보0.9%배당 수익률1.6%자사주 매입 수익률총 주주 수익률2.5%미래 배당 수익률0.9%배당 성장률9.1%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향26%최근 배당 및 자사주 매입 업데이트공시 • May 07Danaher Corporation announces Quarterly dividend, payable on July 31, 2026Danaher Corporation announced Quarterly dividend of USD 0.4000 per share payable on July 31, 2026, ex-date on June 26, 2026 and record date on June 26, 2026.공시 • Feb 25Danaher Corporation Announces Quarterly Dividend, Payable on April 24, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.공시 • Dec 10Danaher Corporation Announces Quarterly Dividend, Payable on January 30, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025.공시 • Sep 10Danaher Announces Quarterly Dividend, Payable on October 31, 2025Danaher Corporation has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025.공시 • May 07Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025.공시 • Feb 21+ 1 more updateDanaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27.모든 업데이트 보기Recent updates공시 • May 07Danaher Corporation announces Quarterly dividend, payable on July 31, 2026Danaher Corporation announced Quarterly dividend of USD 0.4000 per share payable on July 31, 2026, ex-date on June 26, 2026 and record date on June 26, 2026.공시 • Mar 26Danaher Corporation, Annual General Meeting, May 05, 2026Danaher Corporation, Annual General Meeting, May 05, 2026.공시 • Mar 21Danaher Corporation to Report Q1, 2026 Results on Apr 21, 2026Danaher Corporation announced that they will report Q1, 2026 results at 6:00 AM, US Eastern Standard Time on Apr 21, 2026공시 • Feb 25Danaher Corporation Announces Quarterly Dividend, Payable on April 24, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.공시 • Feb 17+ 1 more updateDanaher Corporation (NYSE:DHR) entered into a definitive agreement to acquire Masimo Corporation (NasdaqGS:MASI) from Politan Capital Management, L.P for $9.5 billion.Danaher Corporation (NYSE:DHR) entered into a definitive agreement to acquire Masimo Corporation (NasdaqGS:MASI) from Politan Capital Management, L.P for $9.5 billion on February 16, 2026. Masimo will become a standalone business unit and brand within Danaher’s Diagnostics segment and will operate autonomously while strengthening Danaher’s offering in acute care settings. In case of termination Masimo will pay $305 million. Danaher expects to fund the acquisition using cash on hand and proceeds from debt financing. The Transaction has been unanimously approved by both Masimo’s Board of Directors and Danaher’s Board of Directors and is subject to the satisfaction or waiver of certain closing conditions, including the receipt of required regulatory approvals, Masimo shareholders approval, HSR act approval. The merger is expected to close in the second half of 2026. Masimo is expected to be accretive to adjusted diluted net earnings per common share by $0.15 to $0.20 in the first full year and approximately $0.70 in the fifth full year following completion of the acquisition. Centerview Partners LLC acted as financial advisor for Masimo Corporation. Morgan Stanley & Co. LLC acted as financial advisor for Masimo Corporation. Lauren S. Boehmke and Melissa Sawyer of Sullivan & Cromwell LLP acted as legal advisor for Masimo Corporation. Matthew Barnett and Richard Brand of White & Case LLP acted as legal advisor for Masimo Corporation. David M. Klein, Daniel E. Wolf, Adam Petravicius, Joanna Schlingbaum, Ellisen Shelton Turner, Jordan D. Peterson, Scott D. Price, David G. Branham, Maddison M. Riddick, Rachael L. Lichman, Joshua N. Korff, Diahndra Burman, Liam N. Murphy and Dean S. Shulman of Kirkland & Ellis LLP acted as legal advisor for Danaher Corporation. Longacre Square Partners acted as strategy and communications advisor to Masimo. Citigroup Inc. (NYSE:C) acted as financial advisor to Danaher Corporation.공시 • Feb 11Danaher Corporation Announces Retirement of Director, Jessica L. Mega, Effective February 5, 2026Danaher Corporation announced that Jessica L. Mega notified the Board of Directors of her retirement from the Board as of February 5, 2026, due to commitments related to her other professional obligations. Dr. Mega's decision was not the result of any disagreement with Danaher on any matter relating to Danaher's operations, policies or practices.공시 • Dec 17Danaher Corporation to Report Q4, 2025 Results on Jan 28, 2026Danaher Corporation announced that they will report Q4, 2025 results at 6:00 AM, US Eastern Standard Time on Jan 28, 2026공시 • Dec 10Danaher Corporation Announces Quarterly Dividend, Payable on January 30, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025.공시 • Nov 08Danaher Corporation Announces Retirement of John T. Schwieters from Its BoardDanaher Corporation announced on November 6, 2025, John T. Schwieters notified the company’s Board of Directors that he has decided not to stand for reelection at the Company’s 2026 annual meeting of shareholders (“2026 Annual Meeting”), and will retire from the Danaher Board as of the 2026 Annual Meeting. Mr. Schwieters’ decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The size of the Board will be reduced from thirteen to twelve members as of the time of Mr. Schwieters’ retirement.공시 • Oct 22Danaher Corporation Provides Revenue Guidance for the Fourth Quarter of 2025 and for the Full Year 2026Danaher Corporation provided revenue guidance for the fourth quarter of 2025 and for the full year 2026. In the fourth quarter, the company expects core revenue to grow in the low single-digit percent range as it expects market conditions to be largely consistent with what the company saw in third quarter. For the full year 2026, the company expects core revenue growth in the 3% to 6% range as it is assuming modest recovery across end markets.공시 • Sep 24Danaher Corporation to Report Q3, 2025 Results on Oct 21, 2025Danaher Corporation announced that they will report Q3, 2025 results at 6:00 AM, Eastern Standard Time on Oct 21, 2025공시 • Sep 10Danaher Announces Quarterly Dividend, Payable on October 31, 2025Danaher Corporation has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025.공시 • Aug 01Danaher Corporation Announces Executive ChangesDanaher Corporation announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan Leiken succeeds Brian Ellis, who will retire after nearly a decade of distinguished service as Danaher's General Counsel. Mr. Ellis will remain at Danaher in an executive officer role through February 2026 to support the transition. Prior to joining Danaher, Mr. Leiken served as Executive Vice President, Chief Legal Officer, and Corporate Secretary at Dollar Tree Inc., a Fortune 150 company, where he oversaw corporate governance, ethics and compliance, sustainability and regulatory affairs. Prior to that, he held the same role at Diebold Nixdorf Inc., a global technology company, where he also led intellectual property, internal audit and ESG functions. Mr. Leiken's career includes serving as a federal prosecutor in the U.S. Attorney's Office for the Southern District of New York, where he was recognized for superior performance by multiple federal agencies. He has also been a partner at a global law firm, advising Fortune 500 companies and major institutions on complex litigation, corporate strategy and regulatory matters. He holds a J.D., cum laude, from the University of Pennsylvania Law School and a B.A. in Political Science, magna cum laude, from Brandeis University.공시 • Jul 22Danaher Corporation Announces Chief Financial Officer Changes, Effective February 28 , 2026Danaher Corporation announced that Matthew Gugino, currently Group Chief Financial Officer of the Company's Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher's Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, Mr. McGrew will continue thereafter as an Executive Vice President of the Company, as he begins a gradual transition to retirement, after more than 20 years with Danaher. Mr. McGrew has served as Danaher's CFO since January 2019. He joined Danaher in 2004 as Director, M&A Finance and served in roles of increasing responsibility including Vice President, Investor Relations from 2009 to 2014 and as a Danaher Group CFO from 2012 to 2018. During his tenure as CFO, Danaher meaningfully increased its growth and margin profile, and nearly doubled both its revenue and market capitalization. Mr. Gugino joined Danaher in 2013 as Director, Investor Relations and served as Vice President, Investor Relations from 2014 to 2022. He has served as Vice President of Financial Planning & Analysis since 2019 and additionally as Group Chief Financial Officer in the Company's Life Sciences Innovations Group since 2021. Prior to joining Danaher, he was a Vice President of Equity Research at Barclays and Morgan Stanley, and an Associate at KPMG. He holds a Bachelor of Science degree in Accounting and a Master of Accountancy and Professional Consultancy from Villanova University.공시 • Jun 28Danaher Corporation(NYSE:DHR) dropped from Russell Top 50 IndexDanaher Corporation(NYSE:DHR) dropped from Russell Top 50 Index공시 • Jun 27+ 1 more updateDanaher Corporation Appoints Greg Milosevich to Executive Vice President, Life Sciences Business, Effective July 1, 2025Danaher Corporation announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the Life Sciences Innovations Group since 2021. With this expanded role, he will become an executive officer of Danaher and will continue reporting to Rainer Blair, President and Chief Executive Officer. Mr. Milosevich joined Danaher in 2010, through the acquisition of Molecular Devices, and since has held roles of increasing responsibility across multiple businesses. In his most recent role, as Vice President and Group Executive, Life Sciences Innovations Group, Mr. Milosevich oversaw multiple Danaher companies, including Beckman Coulter Life Sciences, Sciex, Leica Microsystems, Molecular Devices, Phenomenex, Abcam, IDBS and Genedata. He holds a bachelor's degree in physics from the University of Puget Sound, graduating Summa Cum Laude.공시 • Jun 18Danaher Corporation to Report Q2, 2025 Results on Jul 22, 2025Danaher Corporation announced that they will report Q2, 2025 results at 6:00 AM, US Eastern Standard Time on Jul 22, 2025공시 • May 07Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025.공시 • Mar 28Danaher Corporation, Annual General Meeting, May 06, 2025Danaher Corporation, Annual General Meeting, May 06, 2025.공시 • Feb 21+ 1 more updateDanaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: DHRD 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: DHRD 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Danaher 배당 수익률 vs 시장DHRD의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (DHRD)0.9%시장 하위 25% (AR)0%시장 상위 25% (AR)0%업계 평균 (Life Sciences)0%분석가 예측 (DHRD) (최대 3년)0.9%주목할만한 배당금: DHRD 의 배당금( 0.93% )은 AR 시장에서 배당금 지급자의 하위 25%( 0.99% )와 비교해 주목할 만하지 않습니다.고배당: DHRD 의 배당금( 0.93% )은 AR 시장에서 배당금 지급자의 상위 25%( 7.76% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 26.3% )로 DHRD 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 21.4% )이 낮기 때문에 DHRD 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YAR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 22:22종가2026/05/07 00:00수익2026/03/27연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Danaher Corporation는 44명의 분석가가 다루고 있습니다. 이 중 22명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관John EadeArgus Research CompanyCatherine Ramsey SchulteBairdRobert CornellBarclays41명의 분석가 더 보기
공시 • May 07Danaher Corporation announces Quarterly dividend, payable on July 31, 2026Danaher Corporation announced Quarterly dividend of USD 0.4000 per share payable on July 31, 2026, ex-date on June 26, 2026 and record date on June 26, 2026.
공시 • Feb 25Danaher Corporation Announces Quarterly Dividend, Payable on April 24, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.
공시 • Dec 10Danaher Corporation Announces Quarterly Dividend, Payable on January 30, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025.
공시 • Sep 10Danaher Announces Quarterly Dividend, Payable on October 31, 2025Danaher Corporation has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025.
공시 • May 07Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025.
공시 • Feb 21+ 1 more updateDanaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27.
공시 • May 07Danaher Corporation announces Quarterly dividend, payable on July 31, 2026Danaher Corporation announced Quarterly dividend of USD 0.4000 per share payable on July 31, 2026, ex-date on June 26, 2026 and record date on June 26, 2026.
공시 • Mar 26Danaher Corporation, Annual General Meeting, May 05, 2026Danaher Corporation, Annual General Meeting, May 05, 2026.
공시 • Mar 21Danaher Corporation to Report Q1, 2026 Results on Apr 21, 2026Danaher Corporation announced that they will report Q1, 2026 results at 6:00 AM, US Eastern Standard Time on Apr 21, 2026
공시 • Feb 25Danaher Corporation Announces Quarterly Dividend, Payable on April 24, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.
공시 • Feb 17+ 1 more updateDanaher Corporation (NYSE:DHR) entered into a definitive agreement to acquire Masimo Corporation (NasdaqGS:MASI) from Politan Capital Management, L.P for $9.5 billion.Danaher Corporation (NYSE:DHR) entered into a definitive agreement to acquire Masimo Corporation (NasdaqGS:MASI) from Politan Capital Management, L.P for $9.5 billion on February 16, 2026. Masimo will become a standalone business unit and brand within Danaher’s Diagnostics segment and will operate autonomously while strengthening Danaher’s offering in acute care settings. In case of termination Masimo will pay $305 million. Danaher expects to fund the acquisition using cash on hand and proceeds from debt financing. The Transaction has been unanimously approved by both Masimo’s Board of Directors and Danaher’s Board of Directors and is subject to the satisfaction or waiver of certain closing conditions, including the receipt of required regulatory approvals, Masimo shareholders approval, HSR act approval. The merger is expected to close in the second half of 2026. Masimo is expected to be accretive to adjusted diluted net earnings per common share by $0.15 to $0.20 in the first full year and approximately $0.70 in the fifth full year following completion of the acquisition. Centerview Partners LLC acted as financial advisor for Masimo Corporation. Morgan Stanley & Co. LLC acted as financial advisor for Masimo Corporation. Lauren S. Boehmke and Melissa Sawyer of Sullivan & Cromwell LLP acted as legal advisor for Masimo Corporation. Matthew Barnett and Richard Brand of White & Case LLP acted as legal advisor for Masimo Corporation. David M. Klein, Daniel E. Wolf, Adam Petravicius, Joanna Schlingbaum, Ellisen Shelton Turner, Jordan D. Peterson, Scott D. Price, David G. Branham, Maddison M. Riddick, Rachael L. Lichman, Joshua N. Korff, Diahndra Burman, Liam N. Murphy and Dean S. Shulman of Kirkland & Ellis LLP acted as legal advisor for Danaher Corporation. Longacre Square Partners acted as strategy and communications advisor to Masimo. Citigroup Inc. (NYSE:C) acted as financial advisor to Danaher Corporation.
공시 • Feb 11Danaher Corporation Announces Retirement of Director, Jessica L. Mega, Effective February 5, 2026Danaher Corporation announced that Jessica L. Mega notified the Board of Directors of her retirement from the Board as of February 5, 2026, due to commitments related to her other professional obligations. Dr. Mega's decision was not the result of any disagreement with Danaher on any matter relating to Danaher's operations, policies or practices.
공시 • Dec 17Danaher Corporation to Report Q4, 2025 Results on Jan 28, 2026Danaher Corporation announced that they will report Q4, 2025 results at 6:00 AM, US Eastern Standard Time on Jan 28, 2026
공시 • Dec 10Danaher Corporation Announces Quarterly Dividend, Payable on January 30, 2026Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025.
공시 • Nov 08Danaher Corporation Announces Retirement of John T. Schwieters from Its BoardDanaher Corporation announced on November 6, 2025, John T. Schwieters notified the company’s Board of Directors that he has decided not to stand for reelection at the Company’s 2026 annual meeting of shareholders (“2026 Annual Meeting”), and will retire from the Danaher Board as of the 2026 Annual Meeting. Mr. Schwieters’ decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The size of the Board will be reduced from thirteen to twelve members as of the time of Mr. Schwieters’ retirement.
공시 • Oct 22Danaher Corporation Provides Revenue Guidance for the Fourth Quarter of 2025 and for the Full Year 2026Danaher Corporation provided revenue guidance for the fourth quarter of 2025 and for the full year 2026. In the fourth quarter, the company expects core revenue to grow in the low single-digit percent range as it expects market conditions to be largely consistent with what the company saw in third quarter. For the full year 2026, the company expects core revenue growth in the 3% to 6% range as it is assuming modest recovery across end markets.
공시 • Sep 24Danaher Corporation to Report Q3, 2025 Results on Oct 21, 2025Danaher Corporation announced that they will report Q3, 2025 results at 6:00 AM, Eastern Standard Time on Oct 21, 2025
공시 • Sep 10Danaher Announces Quarterly Dividend, Payable on October 31, 2025Danaher Corporation has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025.
공시 • Aug 01Danaher Corporation Announces Executive ChangesDanaher Corporation announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan Leiken succeeds Brian Ellis, who will retire after nearly a decade of distinguished service as Danaher's General Counsel. Mr. Ellis will remain at Danaher in an executive officer role through February 2026 to support the transition. Prior to joining Danaher, Mr. Leiken served as Executive Vice President, Chief Legal Officer, and Corporate Secretary at Dollar Tree Inc., a Fortune 150 company, where he oversaw corporate governance, ethics and compliance, sustainability and regulatory affairs. Prior to that, he held the same role at Diebold Nixdorf Inc., a global technology company, where he also led intellectual property, internal audit and ESG functions. Mr. Leiken's career includes serving as a federal prosecutor in the U.S. Attorney's Office for the Southern District of New York, where he was recognized for superior performance by multiple federal agencies. He has also been a partner at a global law firm, advising Fortune 500 companies and major institutions on complex litigation, corporate strategy and regulatory matters. He holds a J.D., cum laude, from the University of Pennsylvania Law School and a B.A. in Political Science, magna cum laude, from Brandeis University.
공시 • Jul 22Danaher Corporation Announces Chief Financial Officer Changes, Effective February 28 , 2026Danaher Corporation announced that Matthew Gugino, currently Group Chief Financial Officer of the Company's Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher's Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, Mr. McGrew will continue thereafter as an Executive Vice President of the Company, as he begins a gradual transition to retirement, after more than 20 years with Danaher. Mr. McGrew has served as Danaher's CFO since January 2019. He joined Danaher in 2004 as Director, M&A Finance and served in roles of increasing responsibility including Vice President, Investor Relations from 2009 to 2014 and as a Danaher Group CFO from 2012 to 2018. During his tenure as CFO, Danaher meaningfully increased its growth and margin profile, and nearly doubled both its revenue and market capitalization. Mr. Gugino joined Danaher in 2013 as Director, Investor Relations and served as Vice President, Investor Relations from 2014 to 2022. He has served as Vice President of Financial Planning & Analysis since 2019 and additionally as Group Chief Financial Officer in the Company's Life Sciences Innovations Group since 2021. Prior to joining Danaher, he was a Vice President of Equity Research at Barclays and Morgan Stanley, and an Associate at KPMG. He holds a Bachelor of Science degree in Accounting and a Master of Accountancy and Professional Consultancy from Villanova University.
공시 • Jun 28Danaher Corporation(NYSE:DHR) dropped from Russell Top 50 IndexDanaher Corporation(NYSE:DHR) dropped from Russell Top 50 Index
공시 • Jun 27+ 1 more updateDanaher Corporation Appoints Greg Milosevich to Executive Vice President, Life Sciences Business, Effective July 1, 2025Danaher Corporation announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the Life Sciences Innovations Group since 2021. With this expanded role, he will become an executive officer of Danaher and will continue reporting to Rainer Blair, President and Chief Executive Officer. Mr. Milosevich joined Danaher in 2010, through the acquisition of Molecular Devices, and since has held roles of increasing responsibility across multiple businesses. In his most recent role, as Vice President and Group Executive, Life Sciences Innovations Group, Mr. Milosevich oversaw multiple Danaher companies, including Beckman Coulter Life Sciences, Sciex, Leica Microsystems, Molecular Devices, Phenomenex, Abcam, IDBS and Genedata. He holds a bachelor's degree in physics from the University of Puget Sound, graduating Summa Cum Laude.
공시 • Jun 18Danaher Corporation to Report Q2, 2025 Results on Jul 22, 2025Danaher Corporation announced that they will report Q2, 2025 results at 6:00 AM, US Eastern Standard Time on Jul 22, 2025
공시 • May 07Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025.
공시 • Mar 28Danaher Corporation, Annual General Meeting, May 06, 2025Danaher Corporation, Annual General Meeting, May 06, 2025.
공시 • Feb 21+ 1 more updateDanaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 25, 2025Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27.